… diabetes care visits to reduce short-term adverse outcomes and improve glycemic control
in youths with type 1 diabetes. … , randomized clinical trial in 299 youths with type 1 diabetes, …

… This study provides preliminary evidence that clinical pancreatic islet transplantation can be
successfully achieved using a novel immunosuppressive regimen based on efalizumab that …

… The DCCT design has been described elsewhere (1). Briefly, we recruited 1,441 subjects
with 1–15 years duration of type 1 diabetes, minimal or no microvascular complications, and …

… This was a retrospective, cross-sectional, multicenter study performed by the Brazilian Type
1 Diabetes Study Group, by analyzing EuroQol scores from 3,005 participants with Type 1 …

… Our study indicates that the use of CGM during pregnancy in women with type 1 diabetes
is associated with improved neonatal health outcomes attributed to reduced exposure to …

… Type 1 diabetes (T1D) is one of the most prevalent chronic illnesses diagnosed in childhood
and occurs in 1:400–600 American children [1]. An increasing number of young children …

… a study of 44 monozygotic twins discordant for type 1 diabetes (with a mean duration of type
1 diabetes of 14 years), RHR in the type 1 diabetic … Cross-sectional studies have reported an …

… This trial evaluated use in children and teenagers with type 1 diabetes. … of Ireland, and one
in Germany). Eligible patients were: aged 4 to 17 years with type 1 diabetes for a year or more…

… in adults with type 1 diabetes (T1D) who use multiple daily insulin injections. … study, we
examined the QOL measures from the DIAMOND study, both diabetes specific and non–diabetes …

… with both type 1 and type 2 diabetes (6,–8), … type 1 diabetes; however, surprisingly few
studies have examined these effects in pediatric populations. Only one published laboratory study …